Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 11, Issue 1 (2022)

Effect of seed priming treatment on cumin [Cuminum cyminum (L.)] yield and component characters

Author(s):
DP Hansaliya, LD Parmar, YA Viradiya, KN Prajapati and TD Gamit
Abstract:
The investigation on the effect of seed priming treatment on cumin [Cuminum cyminum (L.)] yield and component characters was carried out at Seed Spices Research Station Farm, Sardarkrushinagar Dantiwada Agricultural University, Jagudan, during Rabi 2019-20. Four varieties were taken under consideration, viz., Gujarat Cumin-1, Gujarat Cumin-2, Gujarat Cumin-3 and Gujarat Cumin-4 were obtained from Centre for Seed Spices Research Station, SDAU, Jagudan. Seeds of four varieties were treated with five treatments viz., Control, -1.4 MPa PEG, -1.0 MPa PEG, 0.2% KNO3 and 0.4% KNO3. The experiment was laid out in randomized block design (factorial concept) with three replications comprising five treatment combinations. The combined effect of pre-sowing seed treatment and varieties showed a significant effect for yield and component characters. An experiment of the data under field conditions revealed the maximum plant height (38.72 cm), with treatment 0.4% KNO3 and variety GC-2 combination. At the same treatment (0.4% KNO3) and variety GC-4 combination, the yield attributing characters like maximum number of umbels per plant (82.28), the maximum number of umbellets per umbel (6.37), maximum number of seeds per umbellet (7.37), the maximum number of seeds per umbel (43.64), maximum 1000 seed weight (4.69 g) also show highest mean value, that significantly correlated with seed yield per plant (6.70 g) and seed yield per plot (166.98 g) as compared to the other treatments.
Pages: 120-123  |  530 Views  215 Downloads


The Pharma Innovation Journal
How to cite this article:
DP Hansaliya, LD Parmar, YA Viradiya, KN Prajapati, TD Gamit. Effect of seed priming treatment on cumin [Cuminum cyminum (L.)] yield and component characters. Pharma Innovation 2022;11(1):120-123.

Call for book chapter